Managers learn about the economic situation
Release time:
2020-07-22
Managers Learn Economic Situation
News What kind of policy impact will the "Two Sessions" that ended not long ago bring? How should the Sino-US trade war, which has been going on for more than a year, be dealt? 4# August 4 , the group company invited dr Jiang xinwang, associate professor of Zhejiang normal university and MBA tutor, to give a macroeconomic analysis class to middle and senior managers.
Dr. Jiang Xinwang is an associate professor and master tutor of School of Economics and Management of Zhejiang Normal University, and the director of MBA Education Center. He is mainly engaged in the research and service of macroeconomics, operation and management of small and medium-sized financial institutions, rural finance (especially private finance), financing of small and medium-sized enterprises and risk management, he has published more than 18 30 19 papers in authoritative journals at home and abroad, such as economic theory and economic management, economist, etc., presided over a number of provincial and ministerial research projects, and trained senior managers for nearly 100 enterprises. In a lecture entitled "Policy Interpretation and Macro Policy Situation Analysis of the Two Sessions-In-depth Interpretation of the Sino-US Trade War and Macroeconomic Trends", Jiang Xinwang started from the growth trend of GDP and the characteristics of the middle-income trap in recent years and analyzed the country. The background and reasons for proposing "high-quality development"; combined with a series of new policies introduced during the 18th and 19th National Congress of the Communist Party of China and the new characteristics of China, the domestic economic environment, this paper analyzes the current structural changes of China's economy, and expounds the background of the Sino US trade war, which has been widely concerned and has affected many domestic enterprises in the past year. He pointed out that the root cause of the problems encountered in China's current economic development and the Sino-US trade war is the rapid rise of China's economy and the changes in international trade rules. The Central Economic Work Conference and the 2019 two sessions have a series of new orientations., New policies to further accelerate and deepen the transformation and upgrading of China's economic structure. Under this general trend, only by following the trend and taking the initiative, can enterprises seize the opportunity and seek greater and faster development. Dr. Jiang Xinwang's lecture combines theory with practice, and uses fresh cases in life to simplify and visualize complex and abstract problems, understand the profound and simple, humorous, and the classroom atmosphere is very active, which is welcomed by managers. (this newspaper reporter)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page